🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Research Hypothesis: icotinib administered in combination with gemcitabine ...
Status
Unknown
Location
Cancer Hospital of Harbin Medical University
Start Date
2014-10
Trial ID
NCT02278458
Treatments Being Tested
This is a phase 2 study to evaluate the efficacy of single-agent icotinib i...
Status
Unknown
Location
Multiple Locations
Start Date
2014-11
Trial ID
NCT02328261
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of dose es...
Status
Unknown
Location
Dept. of Oncology,The First Affiliated Hospital of Anhui Medical Univesrsity
Start Date
2014-02
Trial ID
NCT01963195
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerability of Ico...
Status
Completed
Location
West China Hospital
Start Date
2011-12
Trial ID
NCT01516983
Treatments Being Tested
This study is designed to compare the efficacy and safety of first-line ico...
Status
Unknown
Location
Chinese People's Liberation Army (PLA) General Hospital
Start Date
2012-08
Trial ID
NCT01665417
Treatments Being Tested
This phase II randomised, double blind, placebo controlled, multicentre tri...
Status
Unknown
Location
Hunan Province Tumor Hospital
Start Date
2012-09
Trial ID
NCT01707329
Treatments Being Tested
The investigators postulated that the exploitation of the pro-immunogenic e...
Status
Unknown
Location
Hangzhou First People's Hospital
Start Date
2016-05
Trial ID
NCT02787447
Treatments Being Tested
To investigate the efficacy and toxicity of EGFR tyrosine-kinase inhibitor ...
Status
Unknown
Location
Hangzhou Cancer Hospital
Start Date
2015-01
Trial ID
NCT02375581
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of icotini...
Status
Unknown
Location
Baotou Central Hospital
Start Date
2013-06
Trial ID
NCT01926171
Treatments Being Tested
Epidermal growth factor receptor (EGFR) mutations occur in up to 50% of Asi...
Status
Unknown
Location
Multiple Locations
Start Date
2019-07-01
Trial ID
NCT03983811
Treatments Being Tested